BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35763052)

  • 1. Interobserver agreement between eight observers using IOTA simple rules and O-RADS lexicon descriptors for adnexal masses.
    Antil N; Raghu PR; Shen L; Tiyarattanachai T; Chang EM; Ferguson CWK; Ho AA; Lutz AM; Mariano AJ; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2022 Sep; 47(9):3318-3326. PubMed ID: 35763052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver agreement in describing adnexal masses using the International Ovarian Tumor Analysis simple rules in a real-time setting and using three-dimensional ultrasound volumes and digital clips.
    Ruiz de Gauna B; Sanchez P; Pineda L; Utrilla-Layna J; Juez L; Alcázar JL
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):95-9. PubMed ID: 24265132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic diagnosis of adnexal masses: interobserver agreement in the interpretation of videos, using IOTA terminology.
    Massobrio R; Mariani LL; Conti D; De Grandis T; Buonomo F; Badellino E; Novara L; Bounous VE; Perotto S; Mancarella M; Ferrero A; Biglia N; Fuso L
    Arch Gynecol Obstet; 2024 Jan; 309(1):211-218. PubMed ID: 37789207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
    Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
    Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group.
    Vara J; Pagliuca M; Springer S; Gonzalez de Canales J; Brotons I; Yakcich J; Ajossa S; Pascual MA; Guerriero S; Alcazar JL
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
    Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
    J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra- and interobserver agreement with regard to describing adnexal masses using International Ovarian Tumor Analysis terminology: reproducibility study involving seven observers.
    Zannoni L; Savelli L; Jokubkiene L; Di Legge A; Condous G; Testa AC; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):100-8. PubMed ID: 24307182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of differences in O-RADS lexicon interpretation between senior and junior sonologists on O-RADS classification and diagnostic performance.
    Yang Y; Wang H; Liu Z; Su N; Gao L; Tao X; Zhang R; Gu Y; Ma L; Wang R; Xu W; Xie Y; Zhang W; Zhang H; Xue G; Ru T; Dai Q; Li J; Jiang Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12275-12283. PubMed ID: 37430161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.
    Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver and Intraobserver Agreement of Sonographic BIRADS Lexicon in the Assessment of Breast Masses.
    Elverici E; Zengin B; Nurdan Barca A; Didem Yilmaz P; Alimli A; Araz L
    Iran J Radiol; 2013 Sep; 10(3):122-7. PubMed ID: 24348596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the reproducibility of the IOTA simple ultrasound rules for classifying adnexal masses as benign or malignant using stored 3D volumes.
    Guerriero S; Saba L; Ajossa S; Peddes C; Sedda F; Piras A; Olartecoechea B; Aubá M; Alcázar JL
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):157-60. PubMed ID: 24060210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
    Yang Y; Ju H; Huang Y
    Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple Rules, Not So Simple: The Use of International Ovarian Tumor Analysis (IOTA) Terminology and Simple Rules in Inexperienced Hands in a Prospective Multicenter Cohort Study.
    Meys E; Rutten I; Kruitwagen R; Slangen B; Lambrechts S; Mertens H; Nolting E; Boskamp D; Van Gorp T
    Ultraschall Med; 2017 Dec; 38(6):633-641. PubMed ID: 28834973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra- and interobserver reproducibility of assessment of Doppler ultrasound findings in adnexal masses.
    Zannoni L; Savelli L; Jokubkiene L; Di Legge A; Condous G; Testa AC; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):93-101. PubMed ID: 23065868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.